Payment overview · 2025
General Payments
$75.38
3 reported records · 1 companies
Healthcare provider profile · identity verified
Marta E. Abascal Cabrera, ARNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · MIAMI LAKES, FL · NPI 1912480146
Verified facts
What the public records show
CMS Open Payments records show Marta E. Abascal Cabrera, ARNP received $75.38 in general payments during 2025 across 3 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $75.38 | 100.0% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $75.38 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NAVITOR Normalized: navitor |
Device | Abbott Laboratories | $75.38 | 3 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 1557 | 299 |
| Atorvastatin Calcium | Atorvastatin Calcium | 478 | 230 |
| Losartan Potassium | Losartan Potassium | 466 | 212 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 416 | 103 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 411 | 188 |
| Metformin Hcl | Metformin Hcl | 393 | 173 |
| Gabapentin | Gabapentin | 392 | 146 |
| Folic Acid | Folic Acid | 338 | 68 |
| Hydrochlorothiazide | Hydrochlorothiazide | 318 | 153 |
| Lisinopril | Lisinopril | 298 | 141 |
| Levothyroxine Sodium | Levothyroxine Sodium | 261 | 109 |
| Amlodipine Besylate | Amlodipine Besylate | 252 | 116 |
| Baclofen | Baclofen | 237 | 158 |
| Pantoprazole Sodium | Pantoprazole Sodium | 233 | 118 |
| Famotidine | Famotidine | 231 | 101 |
| Metoprolol Succinate | Metoprolol Succinate | 217 | 98 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 212 | 65 |
| Trazodone Hcl | Trazodone Hcl | 209 | 61 |
| Omeprazole | Omeprazole | 203 | 98 |
| Metoprolol Tartrate | Metoprolol Tartrate | 179 | 83 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 176 | 69 |
| Escitalopram Oxalate | Escitalopram Oxalate | 176 | 42 |
| Meclizine Hcl | Meclizine Hcl | 168 | 73 |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 155 | 57 |
| Memantine Hcl | Memantine Hcl | 154 | 44 |
| Alendronate Sodium | Alendronate Sodium | 146 | 53 |
| Sildenafil Citrate | Sildenafil Citrate | 146 | 31 |
| Ezetimibe | Ezetimibe | 136 | 32 |
| Glipizide | Glipizide | 133 | 59 |
| Sertraline Hcl | Sertraline Hcl | 125 | 29 |
| Clonidine Hcl | Clonidine Hcl | 122 | 62 |
| Azithromycin | Azithromycin | 118 | 97 |
| Dicyclomine Hcl | Dicyclomine Hcl | 114 | 33 |
| Donepezil Hcl | Donepezil Hcl | 114 | 44 |
| Montelukast Sodium | Montelukast Sodium | 114 | 60 |
| Alprazolam | Alprazolam | 112 | 38 |
| Eliquis | Apixaban | 112 | 27 |
| Mirtazapine | Mirtazapine | 111 | 26 |
| Celecoxib | Celecoxib | 110 | 67 |
| Clopidogrel | Clopidogrel Bisulfate | 109 | 52 |
| Tamsulosin Hcl | Tamsulosin Hcl | 95 | 56 |
| Latanoprost | Latanoprost | 89 | 19 |
| Furosemide | Furosemide | 82 | 41 |
| Carvedilol | Carvedilol | 81 | 39 |
| Benzonatate | Benzonatate | 75 | 70 |
| Buspirone Hcl | Buspirone Hcl | 74 | 17 |
| Allopurinol | Allopurinol | 72 | 26 |
| Clonazepam | Clonazepam | 72 | 23 |
| Ketoconazole | Ketoconazole | 72 | 46 |
| Temazepam | Temazepam | 72 | 18 |
| Tadalafil | Tadalafil | 70 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 68 | 56 |
| Levofloxacin | Levofloxacin | 68 | 55 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 67 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 66 | 38 |
| Xarelto | Rivaroxaban | 66 | 18 |
| Lactulose | Lactulose | 63 | 38 |
| Hydralazine Hcl | Hydralazine Hcl | 62 | 23 |
| Sucralfate | Sucralfate | 61 | 19 |
| Nifedipine Er | Nifedipine | 58 | 30 |
| Atenolol | Atenolol | 57 | 23 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 56 | 20 |
| Solifenacin Succinate | Solifenacin Succinate | 56 | 14 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 54 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 54 | 43 |
| Enalapril Maleate | Enalapril Maleate | 52 | 20 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 52 | 21 |
| Naproxen | Naproxen | 48 | 43 |
| Glimepiride | Glimepiride | 47 | 22 |
| Insulin Aspart Prot Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 47 | 11 |
| Metronidazole | Metronidazole | 46 | 41 |
| Quetiapine Fumarate | Quetiapine Fumarate | 46 | 15 |
| Simvastatin | Simvastatin | 46 | 26 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 45 | 21 |
| Pradaxa | Dabigatran Etexilate Mesylate | 45 | suppressed |
| Synthroid | Levothyroxine Sodium | 45 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 44 | 16 |
| Chlorthalidone | Chlorthalidone | 43 | 23 |
| Lumigan | Bimatoprost | 43 | suppressed |
| Mupirocin | Mupirocin | 43 | 38 |
| Ondansetron Hcl | Ondansetron Hcl | 42 | 36 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 41 | 37 |
| Januvia | Sitagliptin Phosphate | 40 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 39 | 32 |
| Lorazepam | Lorazepam | 39 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 38 | 12 |
| Pioglitazone Hcl | Pioglitazone Hcl | 38 | 16 |
| Ciclopirox | Ciclopirox | 36 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 36 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 35 | suppressed |
| Pregabalin | Pregabalin | 35 | 11 |
| Sure Comfort Pen Needle | Pen Needle, Diabetic | 34 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 33 | 28 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 33 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 32 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 31 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 31 | suppressed |
| Finasteride | Finasteride | 29 | 16 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Alogliptin | Alogliptin Benzoate | 28 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 27 | 18 |
| Diclofenac Sodium | Diclofenac Sodium | 27 | 16 |
| Gavilyte-C | Peg3350/Sod Sulf,bicarb,cl/Kcl | 26 | 26 |
| Methocarbamol | Methocarbamol | 26 | 17 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 26 | 22 |
| Ammonium Lactate | Ammonium Lactate | 25 | 20 |
| Tramadol Hcl | Tramadol Hcl | 25 | 17 |
| Cilostazol | Cilostazol | 24 | 12 |
| Ibuprofen | Ibuprofen | 24 | 15 |
| Nitroglycerin | Nitroglycerin | 24 | suppressed |
| Prednisone | Prednisone | 24 | 15 |
| Procto-Med Hc | Hydrocortisone | 24 | 18 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 23 | suppressed |
| Carbamazepine | Carbamazepine | 22 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Spironolactone | Spironolactone | 22 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 21 | 15 |
| Glipizide Er | Glipizide | 21 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 20 | suppressed |
| Terconazole | Terconazole | 20 | 17 |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 19 | suppressed |
| Ofloxacin | Ofloxacin | 19 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Ssd | Silver Sulfadiazine | 19 | suppressed |
| Acyclovir | Acyclovir | 18 | 13 |
| Amoxicillin | Amoxicillin | 18 | 18 |
| Brilinta | Ticagrelor | 18 | suppressed |
| Cephalexin | Cephalexin | 18 | 18 |
| Diclofenac Potassium | Diclofenac Potassium | 18 | 13 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 14 |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Loperamide | Loperamide Hcl | 16 | 15 |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 14 | 12 |
| Prolia | Denosumab | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Constulose | Lactulose | 13 | 12 |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Acetic Acid | Acetic Acid | 12 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Potassium Chloride | Potassium Chloride | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Tradjenta | Linagliptin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $75.38 · 3 records | Abbott Laboratories | NAVITOR | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error